4.63
-0.86%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Jinhe Biotechnology Co
Its shares trade on Shenzhen under the ticker 002688.SZ. It has been listed since 13 July 2012. In the fiscal year to 31 December 2025, it reported revenue of CN¥2.88bn and net income of CN¥27.6m. At that date it held total assets of CN¥5.52bn and shareholders' equity of CN¥2.23bn.
Jinhe Biotechnology Co., Ltd. engages in the research, development, production, and sale of animal health products and the provision of related services; environmental-friendly sewage treatment; and deep processing of corns. The company is headquartered in Hohhot, Neimenggu. The company went IPO on 2012-07-13. The firm's main products include animal feed additives, veterinary drug additives, veterinary vaccines and veterinary drugs. The firm is also involved in processing of corn starch, as well as wastewater treatment business. The firm distributes its products in domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 13 Jul 2012
- Employees
- 2,292
- Website
- jinhe.com.cn ↗
Leadership
Pay as last reported
- Mr. Dongxiao WangChairman of the Board, since 2007CN¥578,410
- Mr. Fuzhong LiVice Chairman of the Board, since 2007CN¥444,946
- Mr. Youshan NiuChief Financial Officer
- Mr. Changxian XieGeneral Manager, Director, since 2007CN¥530,712
- Ms. Yueqing WangDeputy General Manager, Director, since 2023
- Mr. Zhijun WangDeputy General Manager, Director, since 2012CN¥96,321
- Mr. Yingzhen GuanDeputy General Manager
- Mr. Mingsheng JianDeputy General Manager
- Mr. Yi LiuDeputy General ManagerCN¥243,602
- Mr. Zhisheng WangDeputy General Manager
- Mr. Xibao YunDeputy General Manager
- Mr. Manman LuSecretary of the Board, Director, since 2023
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Jinhe Biotechnology's animal feed additives are widely used in China's livestock industry.
- The company's veterinary vaccines are recognized for high efficacy in disease prevention.
- Jinhe Biotechnology's corn starch processing supports sustainable agricultural practices.
Weaknesses
- The company's wastewater treatment business faces regulatory challenges in Hohhot.
- Limited international market presence outside China for veterinary drug additives.
- Dependence on domestic market sales for 75% of revenue streams.
Opportunities
- Growing demand for animal health products in Southeast Asia markets.
- Expansion of corn starch processing into new export markets like Japan.
- Increasing government support for environmental-friendly sewage treatment solutions.
Threats
- Stricter regulations on veterinary drug additives in European markets.
- Competition from domestic pharmaceutical companies in China's Health Care sector.
- Fluctuations in corn prices affecting corn starch processing profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.